Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positioned
Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, ...
Wegovy sales double to boost Novo Nordisk's fourth quarter but slower growth predicted
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...
Novo Nordisk Q4 Profit Beats Expectations, Sees Slower Growth in 2025
LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...
Copenhagen Post5h
Greenland announces elections
Greenland’s Prime Minister, Múte B. Egede, announced that the semi-autonomous Danish territory will hold a general election on March 11. The announcement comes amid increasing global attention, ...
ENDPOINTS NEWS2h
No­vo Nordisk sees growth slow­ing this year, plans Ca­griSe­ma fil­ing for 2026
Novo Nordisk reports 26% sales growth in 2024, but projects lower 2025 growth of 16-24%. Full-year Wegovy sales up 86%, ...